Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00640133 · ClinicalTrials.gov registry record · Phase 4

Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder

A Phase 4 study of Obsessive - Compulsive Disorder, sponsored by Butler Hospital.

Active
Registry status
Phase 4
Development phase
27
Enrollment target
9
Study locations

NCT00640133 is a Phase 4 study of Obsessive - Compulsive Disorder that is active but no longer recruiting, run by Butler Hospital. The registered enrollment target is 27 participants, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00640133, a Phase 4 study of Obsessive - Compulsive Disorder, is active but no longer recruiting, sponsored by Butler Hospital.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
27 participants
Enrollment target
9
Study locations

Study Summary

This study will evaluate the safety and effectiveness of deep brain stimulation in treating people with severe and otherwise treatment-resistant obsessive-compulsive disorder.

Conditions Studied

Obsessive - Compulsive Disorder

Interventions

  • DEVICE Sham DBS
  • DEVICE Active DBS

Study Locations (9)

California

  • Kaiser Permanente Redwood City Hospital - Redwood City

District of Columbia

  • George Washington University Hospital - Washington D.C.

Florida

  • University of Florida - Gainesville

Illinois

  • University of Chicago - Chicago

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Ohio

  • The Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-03
Est. Completion 2024-12-01
Phase Phase 4

Sponsor

Butler Hospital

103 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00640133

The ClinicalTrials.gov registry entry for NCT00640133 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,064-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham DBS is the first listed.

NCT00640133 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT00640133 about?

NCT00640133 is a clinical study titled "Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder". This study will evaluate the safety and effectiveness of deep brain stimulation in treating people with severe and otherwise treatment-resistant obsessive-compulsive disorder.

What is the current status of trial NCT00640133?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2008-03. Estimated completion is 2024-12-01.

What conditions does trial NCT00640133 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT00640133?

The interventions under investigation include: Sham DBS (DEVICE), Active DBS (DEVICE).

Who is sponsoring clinical trial NCT00640133?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00640133 being conducted?

This trial has 9 study locations across California, District of Columbia, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obsessive - Compulsive Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.